TITLE

Medical oncology

PUB. DATE
August 1997
SOURCE
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS58
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the research manuscript `Poor prognosis associated with elevated serum CA19-9 level in metastatic colorectal adenocarcinoma,' by A. Wong and A. Chan. Serum tumor marker CA19-9.
ACCESSION #
9708236632

 

Related Articles

  • A New Generation of Molecular Stool Testing. Mak, Tony; Hill, James // Current Medical Literature: Colorectal Cancer;2011, Vol. 4 Issue 4, p105 

    The article discusses the pathophysiology of colorectal neoplasia and describes the existing modalities in molecular stool testing for colorectal cancer (CRC) screening. It says that molecular stool testing can become a significant alternative method to fecal occult blood testing (FBOT). It...

  • Management of local recurrence of colorectal cancer: the role of PET/CT. Bamba, Yoshiko; Itabashi, Michio; Kameoka, Shingo // Abdominal Imaging;May2011, Vol. 36 Issue 3, p322 

    im: The aim was to examine the clinical applicability of positron-emission tomography/computed tomography (PET/CT) for diagnosing local recurrence of colorectal cancer. Methods: From August 2003 to August 2008, 256 patients with colorectal cancer underwent PET/CT scanning for staging or...

  • Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients. Groblewska, Magdalena; Mroczko, Barbara; Gryko, Mariusz; Kędra, Bogusław; Szmitkowski, Maciej // Folia Histochemica et Cytobiologica;2010, Vol. 48 Issue 4, p564 

    The aim of the study was to assess the importance of the measurement of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of matrix metalloproteinases 2 (TIMP-2) in patients with colorectal cancer (CRC) in relation to clinicopathological features of tumor and patients' survival....

  • Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer. Roperch, Jean-Pierre; Incitti, Roberto; Forbin, Solène; Bard, Floriane; Mansour, Hicham; Mesli, Farida; Baumgaertner, Isabelle; Brunetti, Francesco; Sobhani, Iradj // BMC Cancer;2013, Vol. 13 Issue 1, p1 

    Background DNA methylation is a well-known epigenetic mechanism involved in epigenetic gene regulation. Several genes were reported hypermethylated in CRC, althought no gene marker was proven to be individually of sufficient sensitivity or specificity in routine clinical practice. Here, we...

  • Surface-enhanced Raman scattering study of carcinoembryonic antigen in serum from patients with colorectal cancers. Chen, Gang; Chen, Yanping; Zheng, Xiongwei; He, Cheng; Lu, Jianping; Feng, Shangyuan; Chen, Rong; Zeng, Haisan // Applied Physics B: Lasers & Optics;Dec2013, Vol. 113 Issue 4, p597 

    In this work, we developed a SERS platform for quantitative detection of carcinoembryonic antigen (CEA) in serum of patients with colorectal cancers. Anti-CEA-functionalized 4-mercaptobenzoic acid–labeled Au/Ag core-shell bimetallic nanoparticles were prepared first and then used to...

  • Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study. Bertuzzi, Michela; Marelli, Cristina; Bagnati, Renzo; Colombi, Alessandro; Fanelli, Roberto; Saieva, Calogero; Ceroti, Marco; Bendinelli, Benedetta; Caini, Saverio; Airoldi, Luisa; Palli, Domenico // BMC Cancer;2015, Vol. 15 Issue 1, p1 

    Background: Colorectal cancer is one of the major causes of cancer mortality world-wide. Prevention would improve if at-risk subjects could be identified. The aim of this study was to characterise plasma protein biomarkers associated with the risk of colorectal cancer in samples collected...

  • KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers. Phipps, A I; Buchanan, D D; Makar, K W; Win, A K; Baron, J A; Lindor, N M; Potter, J D; Newcomb, P A // British Journal of Cancer;4/30/2013, Vol. 108 Issue 8, p1757 

    Background:Mutations in the Kirsten Ras (KRAS) oncogene are common in colorectal cancer (CRC). The role of KRAS-mutation status as a prognostic factor, however, is unclear. We evaluated the relationship between KRAS-mutation status and CRC survival, considering heterogeneity in this association...

  • Performance of Different Microsatellite Marker Panels for Detection of Mismatch Repair-Deficient Colorectal Tumors. Xicola, Rosa M.; Llor, Xavier; Pons, Elisenda; Castells, Antoni; Alenda, Cristina; Piñol, Virgínia; Andreu, Montserrat; Castellví-Bel, Sergi; Payá, Artemio; Jover, Radriga; Bessa, Xavier; Giros, Anna; Duque, José M.; Nicoiás-Pérez, David; Garcia, Ana M.; Rigau, Joaquin; Gassull, Miquel A. // JNCI: Journal of the National Cancer Institute;2/7/2007, Vol. 99 Issue 3, p244 

    Background Colorectal tumors caused by failure of the DNA mismatch repair system commonly show microsatellite instability. Our goals were to compare the performance of two panels of markers (a panel previously recommended by the National Cancer Institute [NCI] and a pentaplex of mononucleotide...

  • Local colorectal cancer recurrence: pelvic MRI evaluation. Colosio, A.; Fornès, P.; Soyer, P.; Lewin, M.; Loock, M.; Hoeffel, C. // Abdominal Imaging;Feb2013, Vol. 38 Issue 1, p72 

    Surveillance of colorectal cancer is currently based on dosage of tumoral markers, colonoscopy and multidetector row computed tomography. However, pelvic magnetic resonance imaging (MRI) and PET-CT are two second-line useful imaging modalities to assess colorectal cancer local recurrence (LR)....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics